How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

OpenAI may delay its IPO to 2027 amid weak investor sentiment and lofty AI valuation targets; learn what’s driving the ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

Spread the love“`html When you make changes to your domain’s DNS settings, the time it takes for those changes to take effect can be frustrating. This delay is known as DNS propagation speed, and it ...